Migraines

No. Botox® is approved only for chronic migraine, defined as 15 or more headache days per month, and is not indicated for episodic or occasional migraine.

No. While it doesn’t eliminate migraine permanently, regular treatments can significantly reduce attack frequency, intensity, and duration over time.

Not necessarily. Many patients continue preventive or acute medications alongside Botox®, though some are able to taper their medications once Botox® takes effect.

Discomfort is minimal. Most patients feel only a light pinch or pressure at each injection site. Topical numbing is available for added comfort.

No. Although many experience meaningful relief, a minority may see little improvement and require alternative therapies.

Yes, there’s no formal downtime. Still, follow simple aftercare: avoid rubbing or massaging injection sites for 4–6 hours, skip vigorous exercise for 24 hours, and remain upright immediately after treatment. After that, you can resume all normal activities.

Botox® blocks the release of pain-related neurotransmitters and relaxes overactive muscles in the head, neck, and shoulders. Injected at specific sites, it interrupts the pathways that trigger chronic migraine pain.

Yes. Health Canada approved Botox® for the prevention of chronic migraines in 2011; it remains the only neuromodulator indicated for this use.

Treatments are scheduled every 12 weeks. Most patients notice improvement after two cycles, with benefits accruing over subsequent sessions.

The same formulation is used, but migraine therapy employs a distinct dosing and injection pattern across multiple head, neck, and shoulder sites, typically at a higher total dose than cosmetic treatments.

Yes. By relaxing chronically tight muscles in the neck, scalp, and jaw, Botox® can also lessen the frequency and severity of tension-type headaches.

Side effects are uncommon and usually mild, such as localized tenderness, neck stiffness, or minor bruising. Serious adverse events are very rare.